Certara, Inc.

NasdaqGS:CERT 주식 보고서

시가총액: US$1.7b

Certara 관리

관리 기준 확인 2/4

Certara CEO는 Bill Feehery, Jun2019 에 임명되었습니다 의 임기는 5.42 년입니다. 총 연간 보상은 $ 7.81M, 10.2% 로 구성됩니다. 10.2% 급여 및 89.8% 보너스(회사 주식 및 옵션 포함). 는 $ 22.99M 가치에 해당하는 회사 주식의 1.38% 직접 소유합니다. 22.99M. 경영진과 이사회의 평균 재임 기간은 각각 2.3 년과 5.4 년입니다.

주요 정보

Bill Feehery

최고 경영자

US$7.8m

총 보상

CEO 급여 비율10.2%
CEO 임기5.4yrs
CEO 소유권1.4%
경영진 평균 재임 기간2.3yrs
이사회 평균 재임 기간5.4yrs

최근 관리 업데이트

Recent updates

Certara (NASDAQ:CERT) Is Reinvesting At Lower Rates Of Return

Nov 15
Certara (NASDAQ:CERT) Is Reinvesting At Lower Rates Of Return

Is Certara, Inc. (NASDAQ:CERT) Potentially Undervalued?

Oct 24
Is Certara, Inc. (NASDAQ:CERT) Potentially Undervalued?

Certara (NASDAQ:CERT) Seems To Use Debt Quite Sensibly

Sep 20
Certara (NASDAQ:CERT) Seems To Use Debt Quite Sensibly

Certara: Still Awaiting Consistent Growth

Sep 16

Certara, Inc. (NASDAQ:CERT) Shares Could Be 35% Above Their Intrinsic Value Estimate

Aug 31
Certara, Inc. (NASDAQ:CERT) Shares Could Be 35% Above Their Intrinsic Value Estimate

There's Reason For Concern Over Certara, Inc.'s (NASDAQ:CERT) Price

Jul 18
There's Reason For Concern Over Certara, Inc.'s (NASDAQ:CERT) Price

Certara (NASDAQ:CERT) Is Looking To Continue Growing Its Returns On Capital

Jun 13
Certara (NASDAQ:CERT) Is Looking To Continue Growing Its Returns On Capital

When Should You Buy Certara, Inc. (NASDAQ:CERT)?

Apr 11
When Should You Buy Certara, Inc. (NASDAQ:CERT)?

Certara, Inc.'s (NASDAQ:CERT) Share Price Could Signal Some Risk

Mar 21
Certara, Inc.'s (NASDAQ:CERT) Share Price Could Signal Some Risk

Returns Are Gaining Momentum At Certara (NASDAQ:CERT)

Feb 17
Returns Are Gaining Momentum At Certara (NASDAQ:CERT)

Certara: Applied BioMath Acquisition And Simcyp Launch Should Drive Growth

Jan 30

Calculating The Fair Value Of Certara, Inc. (NASDAQ:CERT)

Dec 07
Calculating The Fair Value Of Certara, Inc. (NASDAQ:CERT)

Risks To Shareholder Returns Are Elevated At These Prices For Certara, Inc. (NASDAQ:CERT)

Oct 31
Risks To Shareholder Returns Are Elevated At These Prices For Certara, Inc. (NASDAQ:CERT)

Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)?

Sep 17
Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)?

An Intrinsic Calculation For Certara, Inc. (NASDAQ:CERT) Suggests It's 29% Undervalued

Aug 30
An Intrinsic Calculation For Certara, Inc. (NASDAQ:CERT) Suggests It's 29% Undervalued

Certara (NASDAQ:CERT) Shareholders Will Want The ROCE Trajectory To Continue

Aug 03
Certara (NASDAQ:CERT) Shareholders Will Want The ROCE Trajectory To Continue

Certara: A Story To Watch

Sep 27

Certara to raise capital in secondary stock offering

Aug 12

CEO 보상 분석

Bill Feehery 의 보수는 Certara 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$31m

Jun 30 2024n/an/a

-US$79m

Mar 31 2024n/an/a

-US$61m

Dec 31 2023US$8mUS$796k

-US$55m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

US$19m

Mar 31 2023n/an/a

US$14m

Dec 31 2022US$6mUS$796k

US$15m

Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$10m

Mar 31 2022n/an/a

-US$12m

Dec 31 2021US$6mUS$773k

-US$13m

Sep 30 2021n/an/a

-US$58m

Jun 30 2021n/an/a

-US$55m

Mar 31 2021n/an/a

-US$49m

Dec 31 2020US$4mUS$773k

-US$49m

Sep 30 2020n/an/a

-US$965k

Jun 30 2020n/an/a

US$601k

Mar 31 2020n/an/a

-US$5m

Dec 31 2019US$4mUS$438k

-US$9m

보상 대 시장: Bill 의 총 보상 ($USD 7.81M )은 US 시장( $USD 5.50M ).

보상과 수익: 회사가 수익성이 없는 동안 Bill 의 보상이 증가했습니다.

CEO

Bill Feehery (53 yo)

5.4yrs

테뉴어

US$7,810,028

보상

Dr. William F. Feehery, also known as Bill, Ph.D. serves as Chief Executive Officer of the Certara, Inc. since June 2019 and Director since 2012. He had been the President of Industrial Biosciences Busines...

리더십 팀

이름위치테뉴어보상소유권
William Feehery
CEO & Director5.4yrsUS$7.81m1.38%
$ 23.0m
Leif Pedersen
President & Chief Commercial Officer1.3yrsUS$2.14m0.062%
$ 1.0m
John Gallagher
SVP, Principal Accounting Officer & Chief Financial Officer1.6yrsUS$4.24m0.011%
$ 188.8k
Robert Aspbury
President of Certara Scientific Software4.8yrsUS$2.09m0.18%
$ 2.9m
Patrick Smith
President of Certara Drug Development Solutions3yrsUS$2.42m0.031%
$ 519.0k
Daniel Corcoran
Chief Counselless than a year데이터 없음데이터 없음
Ron DiSantis
Senior Vice President of Corporate Developmentno data데이터 없음데이터 없음
Sheila Rocchio
Chief Marketing Officer1.4yrs데이터 없음데이터 없음
Rona Anhalt
Chief Human Resources Officerless than a year데이터 없음데이터 없음
Frederic Bois
Senior Scientific Advisor5.6yrs데이터 없음데이터 없음
David Mitchell
Senior Vice President of Strategic Engagement3.2yrs데이터 없음데이터 없음

2.3yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 관리: CERT 의 관리팀은 경험 ( 2.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
William Feehery
CEO & Director5.4yrsUS$7.81m1.38%
$ 23.0m
Frederic Bois
Senior Scientific Advisor5.6yrs데이터 없음데이터 없음
James Cashman
Independent Chairman of the Board6.5yrsUS$319.51k0.28%
$ 4.7m
Matthew Walsh
Independent Director4.3yrsUS$252.01k0.12%
$ 1.9m
Eran Broshy
Independent Director2.3yrsUS$252.01k0.014%
$ 238.5k
Malcolm Rowland
Chair of Simcyp Scientific Advisory Boardno data데이터 없음데이터 없음
Yuichi Sugiyama
Member of Simcyp Scientific Advisory Boardno data데이터 없음데이터 없음
Nancy Killefer
Independent Director3.3yrsUS$252.01k0.015%
$ 250.3k
Donald Mager
Member of Simcyp Scientific Advisory Boardno data데이터 없음데이터 없음
Geoff Tucker
Member of Simcyp Scientific Advisory Boardno data데이터 없음데이터 없음
Lawrence Lesko
Member of Simcyp Scientific Advisory Board9.3yrs데이터 없음데이터 없음
J Houston
Member of Simcyp Scientific Advisory Boardno data데이터 없음데이터 없음

5.4yrs

평균 재임 기간

65yo

평균 연령

경험이 풍부한 이사회: CERT 의 이사회는 경험(평균 재직 기간 5.4 년)으로 간주됩니다.